Ribavirin is an antiviral medicine. It's used to treat certain infections caused by viruses. It works by stopping viruses from making copies of themselves. It's often given by injection.
Every report comes from a Lived member, sent anonymously.
Have you tried Ribavirin for Hepatitis C?
Ribavirin is an antiviral medicine used mainly as a partner drug in treating chronic hepatitis C, a long-lasting viral infection of the liver. It was once sold under brand names such as Rebetol, Copegus and Ribasphere, which are no longer marketed in the US; today it is prescribed as a generic capsule or tablet. Ribavirin does not clear hepatitis C on its own and is always combined with other hepatitis C medicines. For many years ribavirin was paired with interferon injections, and its US labeling still describes that use: capsules with interferon alfa-2b for people 3 and older, and tablets with peginterferon alfa-2a (Pegasys) for people 5 and older, including adults who also have HIV. Most people with hepatitis C are now treated with direct-acting antivirals, pills that target the virus itself and usually work without ribavirin. Ribavirin still has a role in harder cases, most notably decompensated cirrhosis, where liver scarring has advanced to the point that the liver is starting to fail. In that group, sofosbuvir/velpatasvir (Epclusa) plus ribavirin is a 12-week regimen, while people who cannot take ribavirin are usually treated for 24 weeks instead. Specialists also use it off-label for chronic hepatitis E in people with weakened immune systems, such as organ transplant recipients. A separate inhaled form, formerly sold as Virazole, is given only in the hospital to infants and young children with severe RSV (respiratory syncytial virus) lung infections. It is not used in adults, and most children with RSV never need it.
Ribavirin is a nucleoside analogue: a molecule that resembles one of the building blocks viruses use to copy their genetic material. Inside the body it is converted to an active form that can block the enzyme hepatitis C uses to copy itself. In laboratory studies it also increases copying errors in several RNA viruses (viruses that carry their genes as RNA rather than DNA, including hepatitis C), which can leave new virus particles defective. Exactly how these effects add up to its benefit in patients is not fully understood. In practice, ribavirin's value is that it strengthens other hepatitis C treatments, helping some regimens work better or over a shorter course. Given alone, it does not cure the infection.
Oral ribavirin comes as 200 mg capsules and as tablets, usually taken twice a day with food. The daily amount is based on body weight, and it is adjusted for kidney function and for side effects, so the prescriber sets the dose and may lower it if anemia develops. Capsules should be swallowed whole, not opened, crushed or broken. Staying well hydrated is advised, especially early in treatment. If a dose is missed, take it as soon as possible on the same day; do not double the next dose. How long treatment lasts depends on the partner medicines: a typical course alongside direct-acting antivirals for decompensated cirrhosis is 12 weeks, while older interferon-based regimens ran 24 to 48 weeks. The inhaled form is given by hospital staff through a special aerosol machine into an infant hood, mask or ventilator, usually for 12 to 18 hours a day over 3 to 7 days.
The main side effect is hemolytic anemia, a drop in red blood cells caused by their breakdown. It usually appears within the first 1 to 2 weeks and can bring tiredness, dizziness, headache and shortness of breath. Blood counts are checked before starting and at weeks 2 and 4, then periodically, and the dose is lowered or paused if anemia becomes significant. Because anemia makes the heart work harder, it has led to heart attacks in people with heart disease. Chest pain during treatment needs medical help right away. When ribavirin is combined with direct-acting antivirals, fatigue, anemia, nausea, headache and trouble sleeping are the most common complaints. When it is combined with interferon, side effects are broader, many of them from the interferon: fever, chills, muscle aches, irritability and mood changes. In that combination, new or worse depression or thoughts of hurting yourself or others need a call to the care team right away. Difficulty breathing, stomach pain with nausea or vomiting (a possible sign of an inflamed pancreas) and changes in vision need the same prompt call. Dry mouth and gum problems can develop over long courses, so brushing twice a day, regular dental checkups and rinsing after any vomiting help protect the teeth. Children treated with ribavirin and interferon often grow more slowly during treatment; most catch up afterward, but some do not reach their expected height.
Ribavirin can cause birth defects, miscarriage or stillbirth, and it can stay in the body for months after the last dose. It must not be used during pregnancy, and men whose partners are pregnant should not take it either. A negative pregnancy test is needed before starting, with repeat tests during treatment and in the months afterward. Women taking ribavirin need effective contraception during treatment and for 9 months afterward; men taking it and their female partners need effective contraception during treatment and for 6 months afterward. The prescriber will confirm the exact period for the product used. A pregnancy during that time should be reported to the prescriber immediately. The inhaled form spreads into the air around the bedside, which matters for anyone pregnant who is caring for the child. Because of the anemia risk, ribavirin is not used in people with significant or unstable heart disease, or with inherited blood disorders such as sickle cell disease or thalassemia major. It is also avoided in people with autoimmune hepatitis. Reduced kidney function calls for a lower dose or may rule ribavirin out, depending on the product: the capsule label excludes people with a creatinine clearance (an estimate of how well the kidneys filter blood) below 50 mL/min, while the tablet label allows reduced doses, including for people on hemodialysis. Ribavirin must never be combined with didanosine, an older HIV medicine, because the combination has caused fatal liver failure, pancreatitis and lactic acidosis (a dangerous buildup of acid in the blood). Taking it with azathioprine, an immune-suppressing medicine, can cause severe drops in all types of blood cells, so the combination needs very close blood monitoring. People who also have HIV need their HIV medicines reviewed, since some combinations raise the risk of anemia and liver problems.
Ribavirin is taken for a fixed course rather than long term. The first weeks bring frequent blood tests, mainly to watch red blood cell levels, along with pregnancy tests where relevant and checks of the hepatitis C virus level. Tiredness from anemia is common and is often handled by lowering the dose rather than stopping treatment. Success is judged after the course ends. The goal is a sustained virologic response, meaning the virus is still undetectable in the blood months after the last dose. People with cirrhosis continue follow-up with their liver team after treatment, and contraception continues for 6 to 9 months after the last dose, depending on who took the medicine.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Ribavirin, what you've noticed, or ask the community a question.